XML 69 R52.htm IDEA: XBRL DOCUMENT
v3.25.3

Description of Business (Details) - USD ($) | Mar. 13, 2024 | Jul. 31, 2025 | Feb. 28, 2025 | Aug. 31, 2023
--- | --- | --- | --- | ---
Description of Business [Line Items] |  |  |  |
Percentage of issued and outstanding | 67.00% |  |  |
Company raised from third parties (in Dollars) |  |  |  | $ 925,000
Investments cash (in Dollars) |  | $ 1,500,000 | $ 582,000 |
Lipomedix Pharmaceuticals Ltd. [Member] |  |  |  |
Description of Business [Line Items] |  |  |  |
Equity interest |  | 95.00% |  |
RP Finance, LLC [Member] |  |  |  |
Description of Business [Line Items] |  |  |  |
Equity interest | 37.50% |  |  |
Howard S. Jonas [Member] |  |  |  |
Description of Business [Line Items] |  |  |  |
Equity interest | 37.50% |  |  |
Rafael Medical Devices, Inc. [Member] |  |  |  |
Description of Business [Line Items] |  |  |  |
Equity interest |  |  | 73.00% | 31.60%
Company raised from third parties (in Dollars) |  |  | $ 44,000 |
CS Pharma Holdings, LLC [Member] |  |  |  |
Description of Business [Line Items] |  |  |  |
Equity interest |  | 50.00% |  |
Pharma Holdings, LLC [Member] |  |  |  |
Description of Business [Line Items] |  |  |  |
Equity interest |  | 90.00% |  |
Pharma Holdings, LLC [Member] | Business Combination [Member] |  |  |  |
Description of Business [Line Items] |  |  |  |
Equity interest |  | 67.00% |  |
CS Pharma Holdings, LLC One [Member] |  |  |  |
Description of Business [Line Items] |  |  |  |
Equity interest |  | 45.00% |  |

X
- References No definition available. + Details
Name: | rfl_IssuedAndOutstandingOrdinarySharesPercentage
Namespace Prefix: | rfl_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Sum of investments and unrestricted cash as of the balance sheet date. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1 + Details
Name: | us-gaap_InvestmentsAndCash
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount of capital contributed by other unit holders. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 5 -Subparagraph (SAB Topic 4.F) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-5 + Details
Name: | us-gaap_OtherOwnershipInterestsValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | srt_OwnershipAxis=rfl_LipomedixPharmaceuticalsLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_RPFinanceLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_HowardSJonasMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_RafaelMedicalDevicesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_CSPharmaHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_PharmaHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_CSPharmaHoldingsLLCOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |